Clinical Research Institute at Rambam

A very strong interaction exists between cardiovascular disease and thrombosis. A heart attack is caused by a clot or thrombos within a coronary artery; in fact, for this reason, some experts prefer the term atherothrombosis to atherosclerosis in order to emphasize the importance of clotting as a life-threatening complication of arterial narrowing and hardening.

Proposed clinical studies to be performed at Rambam include:

» A search for better and safer anticoagulants (known to the public as blood thinners) intended to prevent both arterial (coronary and brain) and venous (leg and lung) thrombosis

» A quest for new biomarkers in the blood beyond the classic markers (e.g., lipids and blood sugars) indicative of heart disease

» Pharmacogenomic inquiries into why individuals respond differently to the same heart and blood medications